Ad is loading...
DGIEX
Price
$20.85
Change
-$0.19 (-0.90%)
Updated
Nov 15 closing price
FNWFX
Price
$80.36
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

DGIEX vs FNWFX

Header iconDGIEX vs FNWFX Comparison
Open Charts DGIEX vs FNWFXBanner chart's image
BNY Mellon Global Emerging Mkts - I
Price$20.85
Change-$0.19 (-0.90%)
VolumeN/A
CapitalizationN/A
American Funds New World F3
Price$80.36
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
DGIEX vs FNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DGIEX vs. FNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGIEX is a Buy and FNWFX is a Buy.

FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 60.9B vs. DGIEX (395M). FNWFX pays higher dividends than DGIEX: FNWFX (1.56) vs DGIEX (0.92). DGIEX was incepted earlier than FNWFX: DGIEX (11 years) vs FNWFX (8 years). DGIEX is a more actively managed with annual turnover of: 44.72 vs. FNWFX (32.00). DGIEX has a lower initial minimum investment than FNWFX: DGIEX (1000) vs FNWFX (1000000). FNWFX annual gain was more profitable for investors over the last year : 11.59 vs. DGIEX (7.88). DGIEX return over 5 years is better than : 30.83 vs. FNWFX (17.23).
DGIEXFNWFXDGIEX / FNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years8 years-
Gain YTD3.9907.14756%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets395M60.9B1%
Annual Yield % from dividends0.921.5659%
Returns for 1 year7.8811.5968%
Returns for 3 years-26.33-14.49182%
Returns for 5 years30.8317.23179%
Returns for 10 years44.17N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EDU55.900.85
+1.54%
New Oriental Education and Technology Group
HTGC18.92-0.13
-0.68%
Hercules Capital
AZ6.49-0.11
-1.67%
A2Z Cust2Mate Solutions Corp
REPL10.80-0.60
-5.26%
Replimune Group
POAI0.69-0.05
-7.23%
Predictive Oncology